Parts matching “SpCas9” · all types
RNA-guided DNA endonuclease from Streptococcus pyogenes that cleaves double-stranded DNA at sites specified by a 20-nucleotide guide sequence, requiring an NGG PAM immediately 3' of the target. The most widely used nuclease for mammalian genome editing.
Enhanced-specificity variant of Streptococcus pyogenes Cas9 carrying alanine substitutions in the protein groove that binds the nontarget DNA strand. eSpCas9 cleaves the same NGG PAM sites as wild-type SpCas9 with a 20-nucleotide guide, but tolerates far fewer guide-target mismatches and so produces less off-target editing in human cells.
Enhanced-specificity variant of Streptococcus pyogenes Cas9 carrying the K848A, K1003A, and R1060A substitutions in the groove that binds the nontarget DNA strand. Cleaves the same NGG PAM sites as wild-type SpCas9 with a 20-nucleotide guide, but tolerates far fewer guide-target mismatches, reducing off-target editing in human cells while retaining robust on-target activity.
High-fidelity variant of Streptococcus pyogenes Cas9 carrying four alanine substitutions that remove non-specific contacts to the target DNA backbone, which reduces off-target cleavage while leaving NGG PAM recognition and guide-directed cleavage intact. Used where genome-wide editing specificity matters more than maximum on-target activity.
RNA-guided DNA endonuclease from Staphylococcus aureus that cleaves double-stranded DNA at sites specified by a 21- to 23-nucleotide guide sequence, requiring an NNGRRT PAM immediately 3' of the target. At 1,053 amino acids it packages together with its guide RNA inside a single AAV vector, which SpCas9 does not.
SpCas9 variant carrying the D10A substitution in the RuvC catalytic domain, which leaves only the HNH domain active so the enzyme nicks the DNA strand complementary to the guide RNA instead of cutting both strands. Used in pairs with offset guide RNAs for high-specificity editing, and as the DNA-binding nickase of cytosine and adenine base editors.
Catalytically inactive Cas9 that binds DNA at guide-specified sites without cleaving it, produced by the D10A and H840A substitutions in the RuvC and HNH nuclease domains of Streptococcus pyogenes Cas9. Retains 20-nucleotide guide targeting and the NGG PAM requirement, and serves as the programmable DNA-binding scaffold for CRISPRi, CRISPRa, and epigenome editing fusions.
Engineered variant of Staphylococcus aureus Cas9 carrying three substitutions in the PAM-interacting domain - E782K, N968K, and R1015H - that relax the wild-type NNGRRT PAM to NNNRRT. Expands the number of targetable genomic sites two- to fourfold over wild-type SaCas9 while retaining its compact size for single-AAV delivery.
Evolved SpCas9 variant that recognizes a wider set of PAM sequences than the NGG PAM required by wild-type SpCas9, including NG, GAA and GAT. Generated by phage-assisted continuous evolution, the xCas9 3.7 clone also shows lower genome-wide off-target activity than SpCas9 at the same target sites.
Cas9-like DNA endonuclease designed by large language models trained on more than 1 million natural CRISPR operons, rather than isolated from an organism. Cleaves double-stranded DNA at guide-RNA-specified sites using an NGG PAM and canonical SpCas9 single-guide RNA scaffolds, while differing from SpCas9 by more than 400 amino acid substitutions.
Compact SaCas9-based cytosine editor split via Npu intein for dual-AAV delivery. Smaller size than SpCas9 enables efficient packaging.
RNA-guided DNA endonuclease from the Streptococcus thermophilus CRISPR1 locus that cleaves double-stranded DNA at sites specified by a guide RNA, requiring a longer, more restrictive NNAGAAW PAM than SpCas9's NGG. Its compact size allows the nuclease and its guide RNA to be packaged together in a single AAV vector for genome editing in human cells and mice.
RNA-guided DNA endonuclease from Neisseria meningitidis that cleaves double-stranded DNA at sites specified by a 24-nucleotide guide sequence and requires an NNNNGATT PAM immediately 3' of the target. Compact enough to package with its own guide RNA in a single AAV vector.
RNA-guided DNA endonuclease from a class 2 type V CRISPR-Cas system, formerly named Cpf1, that cleaves double-stranded DNA at sites specified by a single crRNA and requires a T-rich PAM immediately 5' of the target. Cas12a needs no tracrRNA and leaves staggered ends with 5' overhangs instead of the blunt ends Cas9 produces.
RNA-guided DNA endonuclease from Acidaminococcus sp. BV3L6, formerly named AsCpf1, that cleaves double-stranded DNA at sites specified by a single crRNA and requires a T-rich PAM immediately 5' of the target. It needs no tracrRNA and leaves staggered ends with 5' overhangs. One of two Cpf1-family nucleases, with LbCas12a, that edit human cells robustly.
Al3Cas12f is a compact, naturally occurring CRISPR-Cas12f nuclease from Alistipes sp. identified through metagenomic screening. It forms an obligate homodimer with a 134-nucleotide guide RNA and cleaves double-stranded DNA at TTTV PAM sites, achieving higher editing efficiency in human cells than related Cas12f orthologs.
OsCas12f1 is a compact, RNA-guided type V-F CRISPR-Cas nuclease from an uncultured Oscillibacter sp. bacterium that cleaves double-stranded DNA in a PAM-dependent manner, recognizing a 5'-YTTH sequence. At 433 amino acids, it functions as an obligate homodimer bound to a single guide RNA and is roughly one-third the size of SpCas9.
RNA-guided DNA endonuclease from the acidophilic bacterium Acidibacillus sulfuroxidans (AsCas12f1), one of the most compact CRISPR-Cas effectors characterized to date at 422 amino acids. A class 2 type V-F/V-U3 Cas12f ortholog, it recognizes a 5' T-rich PAM and cleaves double-stranded DNA, functioning as a genome editor in bacteria and human cells.
Compact RNA-guided DNA endonuclease engineered from Un1Cas12f1, an archaeal Cas12f (Cas14) protein that is inactive in mammalian cells in its natural form. Protein and guide RNA engineering restored robust gene editing, transcriptional activation, and base editing activity in human cells, at roughly 40% the size of SpCas9.